Abstract
BackgroundStroke in Chinese Medicine (CM) includes the concepts of ischemic and hemorrhagic strokes from Western Medicine and is a common disease in Hong Kong. This clinical practice guideline (CPG) aims to evaluate and demonstrate CM treatment options for stroke, provide guideline for local CM practice, and act as a reference for decision makers on drafting CM related health policies.MethodsBased on the principle of multidisciplinary integration and evidence-based medicine, a steering committee oversaw the CPG development process in accordance with a published protocol. Clinical questions and evidences were identified, appraised, and synthesised through systematic literature reviews, text mining, and two rounds of Delphi surveys with a multidisciplinary panel of experts.ResultsIn this CPG, we defined stroke from the perspectives of both CM and Western Medicine, reported corresponding CM treatment options, and carried out evaluation based on levels of evidence and grade of recommendation. Suggested CM interventions include herbal medicine treatment based on pattern differentiation, acupuncture treatment, and nursing care.ConclusionThe target population is Hong Kong stroke patients with prodrome or sequela stage. This CPG is intended to help standardizing CM clinical practice and enhancing efficiency of clinical service in Hong Kong.
Highlights
Stroke in Chinese Medicine (CM) includes the concepts of ischemic and hemorrhagic strokes from Western Medicine and is a common disease in Hong Kong
The main differences in clinical practice guideline (CPG) requirements between Hong Kong and mainland China reflect the emphasis on evidence-based medicine and the regulatory system of CM in Hong Kong that, for example, prevents Chinese Medicine practitioners (CMPs) from prescribing Western medicine and ordering laboratory tests
Limitations of the China Association of Chinese Medicine (CACM) CPGs include a lack of bilingual publications and tailoring of the recommendations to optimize dissemination and implementation in the Hong Kong setting
Summary
Stroke in Chinese Medicine (CM) includes the concepts of ischemic and hemorrhagic strokes from Western Medicine and is a common disease in Hong Kong. This clinical practice guideline (CPG) aims to evaluate and demonstrate CM treatment options for stroke, provide guideline for local CM practice, and act as a reference for decision makers on drafting CM related health policies. Stroke is a neurological disease induced by cerebral infarction, intracerebral hemorrhage, or subarachnoid hemorrhage. It is a major cause of disability and death in the world. The purpose is to evaluate existed CM treatment options for stroke and provide guidance on (1) the classification of CM patterns; (2) Chinese herb treatments; (3) acupuncture and moxibustion treatments; and (4) an evidence-based CM regimen for the management of stroke in Hong Kong
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
